产品名称 | NebuSelect™ Recombinant Cynomolgus NPR1/NPRA, mFc-tag |
---|---|
目录号 | NBL-241138 |
别名 | NPR1/NPRA |
外观 | see COA |
分子量 | Gly33-Glu473 |
CAS | N/A |
溶解度 | Water Soluble |
存储条件 | Short term 4℃; Long term -20℃. |
保存时间 | 2 years |
备注1 | XP_005541810.1 |
备注2 |
目录号 | 规格 | 价格 | 库存状态 | |
NBL-241138-100ug | 100ug | Inquire | Inquire | |
NBL-241138-1mg | 1mg | Inquire | Inquire | |
NBL-241138-Customized Size | N/A | Inquire | Inquire |
Product Name:
NebuSelect™ Recombinant Cynomolgus NPR1/NPRA, mFc-tag
Catalog#:
NBL-241138
Description:
NebuSelect™ Recombinant Cynomolgus NPR1/NPRA, mFc-tag(Cat#NBL-241138) is expressed in HEK293 with mFc (IgG1) tag at the C-terminus.It contains Gly33-Glu473.
Species:
Cynomolgus
Expression System:
HEK293
Molecular Weight:
The protein has a predicted MW of 74.56 kDa. Due to glycosylation, the protein migrates to 80-110 kDa based on Bis-Tris PAGE result.
Target Name:
NPR1/NPRA
Target Information:
NPR1 (natriuretic peptide receptor 1), a receptor of ANP (atrial natriuretic peptide) whitch acting through NPR1, provokes hypotension. NPR1 was abundantly expressed in endothelial cells and smooth muscle cells of small arteries and arterioles. NPR1 plays a crucial role in ANP-mediated blood pressure regulation, presumably by a mechanism that is RGS2-dependent in the acute phase and RGS2-independent in the chronic phase.
Amino Acid Sequence:
Gly33-Glu473
Purity:
>95%
Formulation:
see COA
Endotoxin:
<1EU/ug(LAL Method)
Storage:
4°C for short term.
-20°C for long term.
To get more information, please contact us freely.